It was recently announced that the book Surviving James Dean will be adapted for the big screen, a memoir from the actor’s good friend, one-time roommate, and alleged former lover William Bast ...

I’m A Celebrity's Dean McCullough has put himself in the firing line after quitting his very first Bushtucker Trial. The Radio 1 presenter shouted "I'm A Celebrity... Get Me Out Of Here!" after ...

Buccaneers cornerback Jamel Dean has been out of action ever since exiting the team's game against the New Orleans Saints with a hamstring injury. The Bucs haven't won since that game, and part of ...

When I put in my WEN by Chaz Dean order, it said no active WEN orders existed!! Dealing with this company is a nightmare. It wasn't always. It used to be pleasant and swift. Now when I actually ...

Also Read: Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial The results were shared at the American College of Rheumatology ...

A phase 3 trial of Biogen (NASDAQ:BIIB) and UCB's (OTCPK:UCBJF)(OTCPK:UCBJY) dapirolizumab pegol for systemic lupus erythematosus met its primary endpoint, demonstrating significant improvement in ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing ...

Needham forecasts Biogen revenues to remain stable until 2025, rising ~3% by 2026. Biogen will face ongoing challenges as expectations for Leqembi need to adjusted to more realistic levels.

What is Dean Castle Country Park parkrun? A free, fun, and friendly weekly 5k community event. Walk, jog, run, volunteer or spectate – it's up to you!

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.

The two companies have been partnered on Samsung Bioepis for the best part of a decade, successfully bringing six biosimilar copies of biologic drugs to regulatory approval, but Biogen now says it ...